Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 16.47% is 28% above its 5-year average of 12.89%, around the middle of its 5-year range (5.78%–24.49%).
As of the fiscal period ended Tuesday, June 30, 2026. 13.60% above its 12-month average of 14.50%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 16.47%.
DEBT TO ASSETS RATIO
16.47%
DEBT TO ASSETS RATIO AVG TTM
14.50%
DEBT TO ASSETS RATIO AVG 3Y
11.30%
DEBT TO ASSETS RATIO AVG 5Y
12.89%
DEBT TO ASSETS RATIO AVG 10Y
9.30%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+13.60%
CURRENT VS 3Y AVG
+45.72%
CURRENT VS 5Y AVG
+27.76%
CURRENT VS 10Y AVG
+77.09%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+18198.36%
vs the sector median at left
Voyager Therapeutics, Inc.
Market Cap
$148.64M
Debt to Assets Ratio
16.47%
TTM Avg
14.50%
3Y Avg
11.30%
5Y Avg
12.89%
Market Cap
$148.73M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$148.27M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$149.36M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$146.62M
Debt to Assets Ratio
0.27%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$146.27M
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$151.01M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$152.72M
Debt to Assets Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | $148.64M | 16.47% | 14.50% | 11.30% | 12.89% |
| Korsana Biosciences, Inc. (KRSA)vs › | $148.73M | 0.00% | N/A | N/A | N/A |
| Anavex Life Sciences Corp. (AVXL)vs › | $148.27M | 0.00% | N/A | N/A | N/A |
| ALX Oncology Holdings Inc. (ALXO)vs › | $149.36M | 0.06% | N/A | N/A | N/A |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $146.62M | 0.27% | N/A | N/A | N/A |
| Codexis, Inc. (CDXS)vs › | $146.28M | 0.60% | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $146.27M | 0.20% | N/A | N/A | N/A |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.01M | 0.00% | N/A | N/A | N/A |
| Veraxa Biotech Holding AG (VRXA)vs › | $152.72M | N/A | N/A | N/A | N/A |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $143.84M | 0.00% | N/A | N/A | N/A |
Debt/Assets
16.5%
Debt/Equity
0.21
Current Ratio
7.51
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 16.47% |
| 2026-03-31 | 15.76% |
| 2025-12-31 | 14.47% |
| 2025-09-30 | 13.31% |
| 2025-06-30 | 12.48% |
| 2025-03-31 | 11.89% |
| 2024-12-31 | 11.12% |
| 2024-09-30 | 10.64% |
| 2024-06-30 | 10.76% |
| 2024-03-31 | 10.21% |
| 2023-12-31 | 5.78% |
| 2023-09-30 | 7.14% |
| 2023-06-30 | 6.89% |
| 2023-03-31 | 6.67% |
| 2022-12-31 | 14.51% |
| 2022-09-30 | 13.03% |
| 2022-06-30 | 12.87% |
| 2022-03-31 | 19.12% |
| 2021-12-31 | 22.79% |
| 2021-09-30 | 24.49% |
| 2021-06-30 | 21.90% |
| 2021-03-31 | 19.66% |
| 2020-12-31 | 18.20% |
| 2020-09-30 | 11.79% |
| 2020-06-30 | 10.96% |
| 2020-03-31 | 10.35% |
| 2019-12-31 | 9.63% |
| 2019-09-30 | 9.25% |
| 2019-06-30 | 9.12% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 54.84% |
